Atlas FDA

QuickFlex u, Quartet Cardiac Resynchronization Therapy (CRT) Passive Fixation Leads

FDA premarket approval P030054/S366 · decided 2018-12-05

Approval details

PMA number
P030054
Supplement
S366
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
QuickFlex u, Quartet Cardiac Resynchronization Therapy (CRT) Passive Fixation Leads
Generic name
Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Applicant
ABBOTT MEDICAL
Date received
2018-11-23
Decision date
2018-12-05
Days to decision
12 days
Decision code
OK30
Product code
NIK
Advisory committee
Cardiovascular
Expedited review
No
Location
Sylmar, CA
Statement
Introduce periodic particulate matter testing and equipment to the Malaysia and Puerto Rico manufacturing facilities.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18